The integration of single-cell transcriptomics further uncovered MTM1 upregulation in malignant hepatocytes, suggesting that triaptosis activation could selectively target tumor cells while sparing normal tissues—a critical advantage for therapeutic development. Here, MTM1 is linked to neoplasm.